Theme: Form a cancer free globe

Asia Pacific Oncologists 2016

Renowned Speakers

Asia Pacific Oncologists 2016

Conference Series LLC  invites all the participants across the globe to attend the “13th Asia-Pacific Oncologists Annual Meeting” slated on October 17-19, 2016 at Kuala Lumpur, Malaysia.

Asia-Pacific Oncologists  is a global platform to discuss and learn about Cancer Pathways, Neuro Oncology, Oral Cancer, Skin cancer, Blood and Bone Cancer, Lung cancer, renal cancer, Breast Cancer, Pancreatic and colorectal cancer, Reproductive Cancers, Cancer Therapy and Scenario of Cancer.

Track 1: Pathophysiology of Cancer :

Cancer is disease of regulation of tissue growth. In order for a normal cell cancer cell transformation, genes which regulate cell growth and differentiation must be altered. Theories about Cancer include Cancer Cellular transformation and Cancer Derangement theory and Failure of the Immune Response Theory.

A cancer biology study explains the microenvironment, metastasis, angiogenesis, apoptosis, transcription, invasion, suppression of tumor genes, oncogenes, cancer stem cells, conflict to therapy and modelling of tumor. Understanding the Cancer genome may also help a doctor select the best treatment for individual patient. Before cancer cells form in tissues of the body, the cells go through abnormal changes called hyperplasia and dysplasia. In dysplasia, the cells look abnormal under a microscope but are not cancer. Hyperplasia and dysplasia may or may not become cancer.

Related Cancer Conferences:

4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai,UAE; 2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016  Dallas, USA; ESMO Symposium on Signalling Pathways in Cancer  Focusing on the HER/EGFR Family Signalling, Mar 04–05 Spain, Italy; Global Cancer: Occurrence, Causes and Avenues to Prevention June 8-10 Lyon, France ; Antibodies as Drugs March 6–10  2016 Whistler, Canada ; The Cancer Genome March 13-18, CA, USA ; Cancer Cytopathology in Health and Disease February 21–24,San Fanto United States; Enhancer Malfunction in Squamous Cell Cancer February 21–24,2016 ; Molecular and Cellular Basis of Growth and Regeneration (A3), January 10-14, 2016 Breckenridge, USA ; American Cancer Society; American Association for cancer research; American Neuroma Association; Association of oncology Social work; The Association for Cancer Surgery (BASO)

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 2: Neurological Cancer:

Neuro Oncology appraises and treats people with primary and secondary tumors of the brain, spinal cord, and the membranes adjacent the brain and spinal cord (meninges). The maximum kind of brain tumors are glioma, meningiomas, schwannomas of vestibular region and primitive medulloblastoma. The word glioma includes glioblastomas, astrocytomas, oligodendroglioma, and ependymomas. Neuro-oncology in the Paediatric patients is a fast developing arena. A multitude of molecular paediatric brain tumors. The current research focus on clinical research and treatment of primary brain tumors, neoplastic meningitis, brain metastases, epidural cord compression, neurotoxicities, anticancer agents, and Cancer pain management.

Related Cancer Conference:

Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy ; 10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany ; Global Summit on Melanoma and Carcinoma July 14-15, Brisbane, Australia; International Conference on Neuro-Oncology July 21-23, Brisbane, Australia; 17th International Symposium on Pediatric Neuro-Oncology (ISPNO 2016) June 12 - 16, Liverpool, USA;140th Annual Meeting of the American Neurological Association 11 -15 September, Sheraton Park, Sydney;11th European Congress of Neuropathology (ECNP) July 06-09, Bordeaux, France; 10th FENS Forum of Neuroscience July 02- 06  Brussels, Belgium; 17th Biennial Canadian Neuro-Oncology June 9-11 Toranto, Canada. Major Cancer Associations in Kuala Lumpur and Malaysia; Malaysian Anti-Cancer Association; Global Initiative against HPV and Cervical Cancer; Global Lung Cancer Coalition (GLCC) ; Association of oncology Social work

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 3: Oropharyngeal Cancer:

Oral cancer appearances like as a growth, sore in the oral cavity that does not go away. Oral cancer, which contains cancerous cells of the lips, tongue, base of the mouth, both the palates, sinuses, and throat, can be life intimidating if not analysed and treated early stages. Infection with carcinogenic types of human papillomavirus (HPV), especially HPV-16, is a risk factor for most types of head and neck cancers. Other types of head and neck cancers include: Oesophagus Cancer, Larynx Cancer, Nasopharynx Cancer and Thyroid Cancer.

Related Cancer Conference:

International Conference on Tumour Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; International Conference on Pediatric Oncology August 04-06, 2016 Toronto, Canada; Oral Mouth and Throat Cancer Conference August 18-20, 2016 Portland, USA; International Conference on Surgical Oncology, September 01-03, 2016 Sao Paulo, Brazil; International Conference on Molecular Biomarkers and Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 6th World Congress on Head and Neck Oncologic Societies, September 1-5, 2016 Buenos Aires, Argentina;18th International Conference on Oral Surgery, Medicine, Pathology and Radiology Venice, Italy; 7th European Congress on Head and Neck Oncology April 27-30,Istanbul, Turkey 2016; Annual meeting on Supportive  Cancer care June 23–25,2016; 9th International Conference on Head and Neck Cancer July 16 - 20, 2016; American Cancer Society ;American Association for cancer research; American Neuroma Association; Cancer Research Institute; National Cancer Society of Malaysia ; National Cancer Institute ; Cancer Research UK

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 4: Dermatological Cancer:

The most hazardous type of skin cancer is the cancerous growths develop once unrepaired DNA damage to skin cells most regularly caused by UV radiation from sun or tanning beds triggers mutations genetic defects that prime the skin cell to grow rapidly and form cancerous tumors The majority of melanoma are black or brown, but they can also be skin-colour, pink, blue red and purple or may be white.

Mohs surgery had acknowledged as the solitary most actual method for destroying Cell Basal Carcinomas and Squamous Cell Carcinomas are the two most common skin cancers.

Related Conference:

International Conference on Oncology Nursing and Cancer Care September 19-21, 2016 Las Vegas, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; International Conference on Leukaemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; International Conference on Neuroendocrine Cancer and Treatment Aug 1-3, 2016 Toronto, Canada; International Conference on Molecular biomarkers and  Cancer Biomarkers September 15-17, 2016 Berlin, Germany; American Head and Neck Society (AHNS) Annual Meeting April 26-30, San Diego, USA; Enhancer Malfunction in Cancer (Q6) February 21-24,  2016 New Mexico, USA; 2nd EORTC Cancer Survivorship Summit 31 March -1 April 2016, Brussels, Belgium; NCCN 21st Annual Conference: Advancing the Standard of Cancer Care, March 31 - April 1, 2016 Hollywood, USA; Association of oncology Social work ; The Association for Cancer Surgery (BASO); Global Initiative against HPV and Cervical CancerGlobal Lung Cancer Coalition (GLCC); International Gynecologic Cancer Society ; Major Cancer Associations in Kuala Lumpur and Malaysia.

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 5: Blood and Bone Cancer:

Furthermost blood cancers are the normal blood cell enlargement process are interrupted by uninhibited growth of an abnormal type of blood cell. Mainly, three basic forms of blood cancer are Leukaemia, Lymphoma and Myeloma. Bone cancer is an uncommon cancer that initiates in a bone. The cancer which can begin in any bone in the body, but it most usually affects the elongated bones that frame the arms and legs. Bone cancer is a cancer of the cells that make up the bones of the body. Bone cancer found in bones, it has frequently started in another organ or another place in the body and has spread to the bones.

Related Conference:

International Conference on Leukaemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA; International Conference on Molecular & Cancer Biomarkers September 15-17,2016 Berlin, Germany; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 17th World Conference on Lung Cancer, December 4–7 Vienna, Austria; Pan Pacific Lymphoma Conference (University of Nebraska Medical Center) July 18 - 22, Koloa, Hawaii; EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, November 29 - December 2, Munich, Germany; 18th Joint ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research, June 18 - 24 ,Zeist;  Netherlands; ASH Meeting on Lymphoma Biology June 18 - 21, Colorado Springs, CO,USA; 6th World Congress on Cancer Therapy, December 01-03, Baltimore, USA; 12th Euro Global Summit on Cancer Therapy September 26-28, London, UK. American Cancer Society ;American Association for cancer research; American Neuroma Association; Cancer Research Institute; National Cancer Society of Malaysia ; National Cancer Institute ; Cancer Research UK

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 6: Pulmonary Cancer:

Lung cancer views primary reason of tumor losses in men and women around the globe and worldwide Cigarette smoking is the main danger cause for expansion of lung cancer. Mesothelioma is a rare category of cancer that grows in the pleura. It is caused by contact to asbestos. Small lung cancer it has named because the cancerous cells are lesser in dimensions. Non-small cell lung cancers consists of majorly three kinds’ Squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.

Related Conference:

European Radiology Congress July 14-15, 2016 Cologne, Germany; International Conference on Radiography November 17-18, 2016 Dubai, UAE; International Conference on Medical Imaging & Diagnosis May 09-10, 2016 Chicago, USA; International Conference on Radiation Oncology September 26-28, 2016 Valencia, Spain. Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; Cancer Center Business Summit, February 24- 25, 2016 Phoenix AZ,USA; ACCC 42nd Annual Meeting: CANCERSCAPE—Policy, Value and Quality, March 2 – 4, Washington, DC ,USA; 10th European Breast Cancer Conference (EBCC-10) March 9–11,  2016 Amsterdam, Netherlands; ESMO Symposium on Signalling Pathways in Cancer, March 4-5, 2016 Sitges-Barcelona, Spain; 2016 Multidisciplinary Head and Neck Cancer Symposium February 18 - 20, 2016 Scottsdale, AZ,USA; Association of oncology Social work ; The Association for Cancer Surgery (BASO); Global Initiative against HPV and Cervical CancerGlobal Lung Cancer Coalition (GLCC); International Gynecologic Cancer Society ; Major Cancer Associations in Kuala Lumpur and Malaysia.

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 7: Renal Cancer:

Wilms tumors are the chief cancers in kids that jump in the kidneys. Most Wilms tumors are unilateral, which means they disturb only one kidney. Most repeatedly there is only one tumor, but 5 – 10 % of children with Wilms tumors have extra one tumor in the similar kidney. About 5% of offsprings with Wilms tumors have bilateral disease, tumors in both kidneys. Clear cell sarcoma in the kidney spreads to other portions of the body which is hard to cure.

Tumor Nodes Metastasis based on three components: Tumor designates size of a specific tumor. Lymph node indicates the cancer had spread to the near lymph nodes and metastasis whether the cancer has spread to distinct organs.

Related Conference:

10th Global Annual Oncologists Meeting July 11-13, 2016 Cologne, Germany; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference on Cancer therapy, March 29-30, 2016 Atlanta USA; International Conference on Neuro-Oncology July 21-23, 2016 Brisbane, Australia; International Conference on Molecular biomarkers and  Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 17th World Conference On Lung Cancer December 4 - 7, 2016 Vienna, Austria;10th European Breast Cancer Conference (EBCC-10) March 9 – 11, 2016 Amsterdam, Netherlands; ESMO Symposium on Signalling Pathways in Cancer (ESMO & EACR) Sitges March 4 – 5, 2016 Barcelona, Spain; Multidisciplinary Head and Neck Cancer Symposium (American Head & Neck Society, ASCO & ASTRO) February 18 – 20, 2016 Scottsdale, AZ; American Cancer Society ; American Association for cancer research; American Neuroma Association; Cancer Research Institute; National Cancer Society of Malaysia ; National Cancer Institute ; Cancer Research UK

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 8: Breast Oncology:

Breast cancer is a cancerous tumor that initiates in the breast cells. Cells in the breast sometimes change, behave generally. The specific changes may central to benign breast environments such as atypical hyperplasia and cysts. They can also lead to tumours such as intraductal papilloma. Benign conditions and tumors are not cancerous. But in some cases, changes to breast cells can origin breast cancer.

Less common types of breast cancer can also develop. These include inflammatory breast cancer, Paget disease in the nipple region and triple negative condition and basal-like breast cancers. Rare types of breast cancer encompass non-Hodgkin lymphoma and sarcoma.

Related Conference:

International Conference and Exhibition on Pediatric Oncology August 04-06, 2016 Toronto, Canada; International Conference on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; International Conference on Thyroid Cancer and Treatment Aug 1-3, 2016 Toronto, Canada; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta USA; IMPAKT 2016 Breast Cancer Conference  May 07 - 09, Brussels, Belgium; 6th International Symposium on Hereditary Breast and Ovarian Cancer 10–13 May, Cairo, Egypt; 19th SIS World Congress on Breast Healthcare May 5–8, Warsaw, Poland; 33rd Annual Miami Breast Cancer Conference March 10-13, Miami, USA; 10th European Breast Cancer Conference (EBCC-10) March 9–11, Amsterdam, The Netherlands; 6th World Congress on Cancer Therapy, December 01-03, 2016 Baltimore, USA; Association of oncology Social work ; The Association for Cancer Surgery (BASO); Global Initiative against HPV and Cervical CancerGlobal Lung Cancer Coalition (GLCC); International Gynecologic Cancer Society ; Major Cancer Associations in Kuala Lumpur and Malaysia.

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 9: Pancreatic and Colorectal Cancer:

 Pancreatic cancer is a disease in which malignant cells form in the tissues of the pancreas. It   regulates blood sugar levels. Exocrine cells produce the digestive juices; while endocrine pancreas cells produce the hormones majorly cancers start in the exocrine cells.   Mostly, colorectal cancer starts in glandular cells, which make mucus and digestive fluids. These cells line the inside of the colon and rectum. This type of cancer is called adenocarcinoma of the colon and rectum. Changes in the cells of the colon and rectum can also cause precancerous conditions.

Related Conference:

4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; International Conference on Pancreatic Cancer and Colorectal Cancer March 29-30, 2016 Atlanta USA; Cancer Diagnostics Conference & Expo June 13-15, 2016 Rome, Italy; International Conference on Tumour Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; ASCO Annual Meeting - American Society Of Clinical Oncology June 02  - 06, Chicago ,USA; ESMO Sarcoma & GIST Conference February 16 - 17, 2016 Milan, Italy; 16th Annual Targeted Therapies of Lung Cancer Meeting (IASLC), February 17 – 20, Santa Monica, CA,USA; 25th Conference of the Asian Pacific Association cancer conference for the Study of the Liver February 20–24, 2016 Tokyo, Japan; ESMO Symposium on Signalling Pathways in Cancer  (ESMO & EACR) March 4 – 5, 2016  Sitges Barcelona, Spain ; American Association for cancer research; American Neuroma Association; Cancer Research Institute; National Cancer Society of Malaysia ; National Cancer Institute ; Cancer Research UK

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 10:  Reproductive Cancers:

Reproductive malignancies originate in the organs associated to reproduction (sex). These organs are located in the pelvis and in the middle of the hip bones. Epithelial tumors arise from the surface of the ovaries. Tumors start in the cells that yields the eggs are termed as germ cell tumors. They can either be benign or cancerous. Most are benign. Stromal tumors initiate in the cells that harvest the female hormones. Prostate cancer is usually a very slow growing cancer, with no symptoms until it is in a progressive stage. Most men with prostate cancer die of other causes, and many never know that they have the disease. But once prostate cancer begins to grow quickly or spreads outside the prostate, it is dangerous.

Related Conference:

Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; 4th Global Radiologists Annual Meeting March 17-18, 2016 London, UK; International Conference on Radiation Oncology September 26-28, 2016 Valencia, Spain; European Radiology Congress July 14-15, 2016 Cologne, Germany; EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium November 29-December 2, 2016 Munich, Germany; ESMO Cancer Congress October 7-11, 2016 Copenhagen, Denmark; Pan Pacific Lymphoma Conference (University of Nebraska Medical Center) July 18–22, 2016 Koloa, Hawaii; SNMMI Annual Meeting Society of Nuclear Medicine and Molecular Imaging, June 11–15, 2016 San Diego, CA,USA; 19th SIS World Congress on Breast Healthcare May 5–8, 2016( Senologic International Society) Warsaw, Poland ; The Association for Cancer Surgery (BASO); Global Initiative against HPV and Cervical CancerGlobal Lung Cancer Coalition (GLCC); International Gynecologic Cancer Society ; Major Cancer Associations in Kuala Lumpur and Malaysia.

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 11: Cancer Therapy:

Hormone therapy varies the quantity of hormones that mingle in the blood and regulate the activity of certain cells. Targeted therapy specifies the targeted genes and proteins that contribute to cancer growth. Immunotherapy is designed to lift the body’s natural defence system for defenders of the cancer.

Related Conference:

International Conference on Neuro-Oncology July 21-23, 2016 Brisbane, Australia; International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; International Conference on Leukaemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; NCCN 21st Annual Conference: Advancing the Standard of Cancer Care, March 31 – April 2,Hollywood, FL; 11th European International Kidney Cancer Symposium, April 29 - 30, 2016 Barcelona, Spain; EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, November 29-December 2, Munich, Germany; Gastrointestinal Cancers Symposium January 21-23, San Francisco, CA; Fourth AACR-IASLC International Joint Conference: Lung Cancer Translational Science January 4 - 7, 2016 San Diego, CA,USA ; American Association for cancer research; American Neuroma Association; Cancer Research Institute; National Cancer Society of Malaysia ; National Cancer Institute ; Cancer Research UK

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 12: Scenario of Cancer:

A biomarker used to check well the body answers to a treatment for a disease or condition. Also called molecular marker and name the molecule. Cancer nanotechnology being an enthusiastically evaluated and implemented in cancer treatment demonstrating a major improvement in detection and diagnosis and treatment of the disease.

Related Conference:

12th Euro Global Summit on Cancer Therapy Sept 26-28, 2016 at London, UK; International Conference on Oncology Nursing and Cancer Care Sept 19-21, 2016 Las Vegas, USA; International Conference and Exhibition on Pediatric Oncology August 04-06, 2016 Toronto, Canada; International Conference on Radiography November 17-18, 2016 Dubai, UAE; International Conference on Tumour Immunology and Immunotherapy July 28-30, Melbourne, Australia; The Biomarker Summit, March 21-23, San Diego, USA; Cancer Vaccines: Targeting Cancer Genes for Immunotherapy March 6-10, Fairmont Chateau Whistler, Canada; Cancer-International Cancer Study & Therapy Conference Feb 22-24, USA; Molecular and Cellular Basis of Growth and Regeneration (A3) January 10-14, Breckenridge, USA; Cancer and Autoimmunity 2016 Emerging Target Therapies in Cancer & Autoimmunity, April 21- 25, 2016 Varadero, Cuba; The Association for Cancer Surgery (BASO); Global Initiative against HPV and Cervical CancerGlobal Lung Cancer Coalition (GLCC); International Gynecologic Cancer Society ; Major Cancer Associations in Kuala Lumpur and Malaysia.

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

Track 13: Nursing Oncology

Nursing oncology provides special care for cancer patients and those at risk for getting the disease. They monitor physical conditions, recommended medication, and direct to chemotherapy and other treatments. Oncology is one of the most challenging and satisfying fields in nursing and no two existences on the job are ever the same.

Related Conference:

International Conference on Oncology Nursing and Cancer Care September 19-21, 2016 Las Vegas, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; International Conference on Leukaemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; International Conference on Thyroid Cancer and Treatment Aug 1-3, 2016 Toronto, Canada; International Conference and Expo on Molecular and Cancer Biomarkers September 15-17, 2016 Berlin, Germany; American Head and Neck Society (AHNS) Annual Meeting April 26-30, San Diego, USA; Enhancer Malfunction in Cancer (Q6) February 21-24,  2016 New Mexico, USA; 2nd EORTC Cancer Survivorship Summit 31 March -1 April 2016, Brussels, Belgium; NCCN 21st Annual Conference: Advancing the Standard of Cancer Care, March 31 - April 1, 2016 Hollywood, USA ; American Association for cancer research; American Neuroma Association; Cancer Research Institute; National Cancer Society of Malaysia ; National Cancer Institute ; Cancer Research UK

Recommended Cancer Conferences | Oncologists Meetings| Conference Series LLC

 Asia-pacific Oncologists 2016 invites all the members across the globe to attend the "13th Asia-Pacific Oncologists Annual Meeting” (Oncologists 2016) slated on October 17-19, 2016 at Kuala Lumpur, Malaysia.

Asia-pacific Oncologists 2016 directs lecturing the main topics as well as forthcoming approaches of oncology. This is going to be the largest and most fortunate international conference in which the program includes Medical Oncologists, entire medical team involved in the arena of cancer to learn values of oncology and highly branches of cancer will come to discuss and debate on numerous aspects of the cancer, possibilities and real research work and complete evidence of oncology. This conference deals with the unique methods of oncology and its innovative strategies. The event is a three day program and the conference theme is “Form a cancer free globe” and henceforth, we are seeking a support of advanced ideas which forms the ambiance of our Medical meetings.

Why to attend???

Join your nobles around the world focused on learning about Oncology and related advances, which is your single best opportunity to reach the largest gathering of participants from the  community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most topical research, advances, and the newest updates in Oncology are hallmarks of this conference.

Target Audience:

  • Business Entrepreneurs Public
  • Health Professionals
  • Drug Manufacturing Companies
  • Radiation Therapist
  • Oncology Societies
  • Clinical Researchers
  • Leading world Doctors
  • Surgical and Medical Oncologists
  • Young Researchers
  • Students & Delegates

Related Societies :

 

American Cancer Society

American Association for cancer research

American Neuroma Association

Cancer Research Institute

National Cancer Society of Malaysia

National Cancer Institute

Cancer Research UK

Association of oncology Social work

The Association for Cancer Surgery (BASO)

Global Initiative against HPV and Cervical Cancer        

Global Lung Cancer Coalition (GLCC)

International Gynecologic Cancer Society

Major Cancer Associations in Kuala Lumpur and Malaysia

Malaysian Oncology society

Malaysian Anti-Cancer Association

National Cancer Council, Malaysia

Breast Cancer Welfare Association Malaysia

Cancer Research Initiatives Foundation

Malaysian Society of Paediatric Haematology and oncology

Malaysian Thoracic Society

 

Oncology is the study of cancer. A doctor who specializes in treating people with cancer is called an oncologist. Usually, an oncologist manages care and treatment once a person is diagnosed with cancer.

There are three main types of oncologists are medical, surgical, and radiation oncologists.

Cancer is a chief burden of disease universally. Yearly, tens of millions of individuals are identified with cancer round the world, and more than half of the patients ultimately die from it. Cancer causes 1 in 8 deaths worldwide and is rapidly becoming a global disease. If rates don’t change, the global cancer burden is expected to rise up to 21.7 million cases and 13 million deaths by 2030.

Scope and Importance:

Based on the latest Health Facts 2013 released by Ministry of Health (MoH) Malaysia, cancer is one of the top ten causes of hospitalisation and one of the top five causes of death in both MoH and private hospitals. The salient truth is that cancer has overtaken hearth disease as the number one killer this year (2014).

Why in Malaysia?

In Malaysia, the incidence of cancer increased from 32,000 new cases in 2008 to about 37,000 in 2012. Mortality due to cancer stood at 20,100 deaths in 2008 and has increased to 21,700 deaths in 2012, according to the International Agency for Research on Cancer (IARC) Globocan of the World Health Organisation (WHO). More than 50% of Malaysian Malay men smoke, more than 30% Malaysians are obese, yet we still do not take screening and prevention seriously.

The most frequent cancers among Malaysians are breast, colorectal and lung cancer, with one in 19 Malaysians developing breast cancer, one in 33 developing colorectal cancer and one in 40 developing lung cancer, according to the World Health Organisation’s Globocan 2008 report.

 "In 2012, lung cancer contributed to 19.9 percent of all deaths caused by cancer in MOH hospitals throughout the country. "This number was followed by 9.6 percent for breast cancer, 8.7 percent for colorectal cancer, 7.3 percent for liver cancer and 6.8 percent for leukemia," he said when contacted.

Conference highlights:

    Pathophysiology of Cancer

    Neurological Cancer

    Oropharyngeal cancer

    Dermatological Cancer

    Blood and Bone Cancer

    Thoracic Cancer

    Renal Cancer

    Breast Oncology

    Pancreatic and Colorectal Cancer

    Reproductive Cancers

    Cancer Therapy

    Scenario of Cancer

    Nursing Oncology

    Entrepreneurs Investment Meet

Why to Attend?

 A stimulating scientific programme will facilitate an exchange of ideas and information on recent findings from a wide variety of specialties in oncology related fields. This is a prestigious opportunity to engage with global community of professionals striving to reduce cancer in the individuals from corner to corner of Malaysia.

Major Cancer Associations across the Globe:

American Cancer Society

American Association for cancer research

American Neuroma Association

Cancer Research Institute

National Cancer Society of Malaysia

National Cancer Institute

Cancer Research UK

Association of oncology Social work

The Association for Cancer Surgery (BASO)

Global Initiative against HPV and Cervical Cancer        

Global Lung Cancer Coalition (GLCC)

International Gynecologic Cancer Society

Major Cancer Associations in Kuala Lumpur and Malaysia

Malaysian Oncology society

Malaysian Anti-Cancer Association

National Cancer Council, Malaysia

Breast Cancer Welfare Association Malaysia

Cancer Research Initiatives Foundation

Malaysian Society of Paediatric Haematology and oncology

Malaysian Thoracic Society

Malaysian Paediatric Association

Statistical Analysis of Associations

Target Audience:

Oncologists, Researchers, Academicians, Physicians , Post Docs, Students , Pharmacy Industries, Academic scientists ,Industry professionals, Diagnostic laboratory professionals.

Top Universities related to cancer in Malaysia:

University Malaya Medical Centre

Universiti Kebangsaan Malaysia Medical Centre

Universiti Sains Malaysia

Universiti Malaysia Sarawak

Universiti Putra Malaysia

International Medical University

Universiti Kuala Lumpur Royal college of Perak

International Islamic University Malaysia

Penang Medical College

University Malaya Medical Centre

Universiti Teknologi MARA

Universiti Malaysia Sabah

Allianze University College of Medical Sciences

Cyberjaya University College of Medical Science Faculty of Medicine

UCSI University Faculty of Medicine and Health Sciences

Monash University Malaysia Campus

Universiti Sains Islam Malaysia

Management and Science University

AIMST University Faculty of Medicine

Universiti Sultan Zainal Abidin

National Defence University of Malaysia

MAHSA University College Faculty of Medicine

Bedong Medical College

Perdana University Royal College of Surgeon in Ireland

SEGi University

Taylor University college of medicine

Universiti Tunku Abdul Rahman

University College Shahputra Faculty of Medicine

Quest International University Perak Faculty of Medicine

Asia Metropolitan University School ofMedical and Health Sciences

Lincoln University College School of Medicine

Pharmaceutical Companies in Global Cancer Market:

The major Companies manufacturing the cancer drugs are Roche, Novartis, Celgene, Johnson & Johnson, Bristol-Myers Squibb, Lilly, Takeda, AstraZeneca, Pfizer, Merck & Co, Bayer, and UCB.

Pharmaceutical Companies in Malaysia

Merck

Antah Healthcare Group 

Orient Europharma Co., Ltd.

Pfizer

Hospitals for Cancer treatment in Malaysia:

Mount Miriam Cancer Hospital

Gleneagles Oncology – Cancer Centre

NCI Hospital

Beacon International Specialist Centre

Mount Miriam Hospital

Oncology Centre (KI) Sdn Bhd

Hospital Serdang

Prince Court Medical Centre

Institute Jantung Negara

Hospital Ipoh

NCI Cancer Hospital (NCICH)

Tung Shin Specialist Hospital

Pantai Medical Centre 

Gleneagles Oncology Centre

Hospital Universiti Kebangsaan Malaysia

Hospital Kuala Lumpur 

Prince Court Medical Centre

Mahkota Medical centre

KPJ Ampang Puteri Specialist Hospital

KPJ Damansara Specialist Hospital

Sunway Medical Centre

Hospitals associated with Cancer

Members Associated in Cancer research:

Members Associated in cancer Research

Market Value for the Cancer:

In 2010, the global cancer market was valued at $54 billion, with forecasted Compound Annual Growth Rate (CAGR) growth to $81 billion by 2016. The seven major cancer markets (US, France, Malaysia, Italy, Spain, United Kingdom and Japan) represented ~79% of the 2010 global cancer market ($43 billion). The US dominated 2010 sales with a market share of 38.5% and the leading ten companies of the global cancer market represented 87.1% ($47 billion) of the total market.

The market value in Malaysia is worth $30 million, and growth will be driven by cancer treatment following early diagnosis of cancers and targeted therapy in the three major cancers - lung, breast and colorectal.  The Asia oncology drug market revenues have grown at a CAGR of 4.3% from 2009-2014.Asia oncology drug market will grow at a considerable CAGR and will exceed over USD 20 billion by 2017

Market Value for Cancer Research in billion $

Amount Funded by the Organisations for All types of Cancers

The numbers of Grants are 1428 for the 15 types of the cancers the funded amount is

707,390,926$

Amount Funded for all Cancers 

Sale Value for the Cancer Drugs

The Sale value for Cancer Drugs that are manufactured by the different Companies Rituximab7.78$ billion manufactured by Roche, Bevacizumab 6.75$ billion manufactured by Roche and Avastin, Trastuzumab 6.56$ billion, Imatinib 4.69$ billion manufactured by Novartis, Pegfilgrastim 4.39$ billion, Lenalidomide 4.28$ billion, Pemetrexed 2.7$ billion, Bortezomib 2.61$ billion, Cetuximab 1.87$ billion, Abiraterone 1.8$ billion.

Oncologists in Malaysia

The Number of the Oncologists in the Malaysia in 2008 is 1717 and it is raised to 2599 by 2015 and by the 2020 the count will be approximately 3306.

Incidence rate for the All Types of Cancers all over the World

The New incidence for all types of Cancer reported all over the world in the 2012 is 14,067,894 and it is gradually increased in 2015 is about 15,206,036 the Demographic change noticed is 1,138,142.

All New cases for all Types of Cancers all over the World

Mortality rate for the All Types of Cancers all over the World

The Death rate all types of Cancers reported all over the world in the 2012 is 8,201,575 and it is gradually increased in 2015 is about 8,885,195 the Demographic change noticed is 683,620.

Death rate for the all Types of Cancers all over the World

Incidence rate for the All Types of Cancers in Malaysia:

The New incidence for all types of Cancer reported in Malaysia in the 2012 is 493,780 and it is gradually increased in 2015 is about 518,653 the Demographic change noticed is 24,873.

Cancer Summit 2015

OMICS Group’s 5th Asia-Pacific Summit on Cancer Therapy at Park Regis Brisbane, Australia during July 20-22, 2015 was organized with a focus on "Forum for a world without cancer was a great success where eminent keynote speakers from various reputed institutions made their resplendent presence and addressed the gathering.

Cancer Summit-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of cancer.

Cancer Summit-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Rupinder Kaur Kanwar, Deakin University, K who contributed a lot for the smooth functioning of this event.

OMICS Group International would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Cancer Summit-2015:

Jagat R Kanwar, Deakin University, Australia

Kwok-nam Leung, The Chinese University of Hong Kong, Hong Kong

Izhak Haviv, Bar Ilan University, Israel

Pascal H G Dujif, University of Queensland, Australia

Veronica J James, Australian National University, Australia

OMICS Group, on behalf of the conference, congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Dr. Izhak Haviv, Bar Ilan University, Israel for his valuable time.

Best Poster Winners:

OMICS Group also took the privilege of felicitating Cancer Summit-2015 Organizing Committee, Editorial Board Members of Journals of Cancer Science & Therapy, Journal of Carcinogenesis & Mutagenesis and Journal of Integrative Oncology, Keynote Speakers, Chair and Co-Chairs and Moderator whose support made conference a great success.

With the enormous feedback from the participants and supporters of Cancer Summit-2015, OMICS Group Conferences is glad to announce


Past Reports  Gallery  

Chemotherapy-2015

 

Over thousands of scholars from the field of Chemotherapy stepped away from their nations last Tuesday, August 2nd, 2015 to take part in an ostentatious event “International Conference on Antimicrobial Agents and Chemotherapy” August 04-06, 2015, in Valencia, Spain. The conference was organized around a single theme “Emerging techniques and advancements in the field of chemotherapy which comprised of 06 tracks with knowledge oriented presentations igniting young minds in the crowd.

The Conference provided a rostrum for interaction among keynotes, chair & co-chairs, plenary speakers, poster presentees, young research fellows & delegates and to share their experiences, ideas & research, thus helping to generate a new way of looking at Cancer treatments.

Conference began with the welcome message given by our moderator Dr. Emil Toma, University of Montreal, USA, followed by a Keynote series of well-known speakers:

  • Dr. Emil Toma, University of Montreal, USA.
  • Dr. Didier Coquoz, Copexis, Switzerland.
  • Dr. Hiroyuki Osada, RIKEN Center for Sustainable Resource Science, Japan.

The session was chaired by Dr. Emil Toma, University of Montreal, USA, preceded with paramount Oral Presentations. The Conference also witnessed an amalgamation of eminent speakers like:

  • Junjun Qiu, Obstetrics and Gynecology Hospital of Fudan University, China.
  • Helene Castel, Universite de Rouen, France
  • Paula Sabbo Bernado, Brazilian National Cancer Institute, Brazil.

The Conference also provided a platform for a grandiose Workshop by:

  • Isabel Portero Sanchez, Universidad Complutense & BIOHOPE Scientific Solutions, Spain
  • Dirk Buscher, Gri-Cel S.A. Spain
  • Eva Martin Becerra, Gradocell& IMMPULSO Medical Sciences, Spain

The second day session was chaired and Keynote speech was given by:

  • Dr. Hiroyuki Osada, RIKEN Center for Sustainable Resource Science, Japan

The session was preceded by Oral Presentations by:

  • Dr. Hiroyuki Osada, RIKEN Center for Sustainable Resource Science, Japan
  • Dr. Minoru Yoshida, RIKEN Center for Sustainable Resource Science, Japan
  • Natalia Martins, Polytechnic Institute of Braganca, Portugal

A Global Platform was given to students to explore their research work under the category Young Research Forum:

  • Bin Li, University of Hong Kong, China
  • Wen WenXu, University of Hong Kong, China
  • Natalia Martins, Polytechnic Institute of Braganca, Portugal
  • Maude Loignon, University of Montreal, Canada

OMICS International acknowledges all the Organizing Committee Members, Moderator, Chair and Editorial Board Members of OMICS group Journals, Speakers, Students, Delegates and Media Partners in making this event a great success. We are also obliged to various government authorities, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members, for their gracious presence, support and assistance.


Past Reports  Gallery  

Cancer Science-2014

 

OMICS Group’s 4th World Congress on Cancer Science & Therapy was held during October 20-22, 2014 at DoubleTree by Hilton Hotel Chicago - North Shore Conference Center, Chicago, USA.

Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals, scientists, researchers, as well as experts in the cancer research, leaders from the fields of Cancer Therapy, and students from diverse groups, who made this conference one of the most successful and productive events in 2014 from OMICS Group.

The conference proceedings were carried out through effectual keynote lectures by:

Dr. Peter Weightman, University of Liverpool, UK
Dr. Sudhakar Akul Yakkanti, SRI International, USA
Dr. Jeffrey B. Ulmer, Novartis Vaccines & Diagnostics, USA
Dr. Reza Hakkak, University of Arkansas for Medical Sciences, USA

This annual conference brought together eminent experts from different countries in which many modern issues were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided a good platform to share their ideas and experiences in the field of cancer therapy.

The conference was greeted by the welcome message by our moderators Juan Jose Marugan, National Institutes of Health, USA and Bernard Friedenson, University of Illinois, USA, and welcomed Honorable guests Sudhakar Akul Yakkanti, SRI International, USA, Anupam Bishayee, California Northstate University, USA, and Reza Hakkak, University of Arkansas for Medical Sciences, USA.

We sincerely acknowledge all the organizing committee members, moderators, chair and co-chairs, editorial board members, speakers, delegates for their gracious presence, and support in making this event successful. OMICS Group has taken the privilege of felicitating Cancer Science-2014 Organizing Committee Members, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2014. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group Journal of Cancer Science & Therapy and Journal of Carcinogenesis & Mutagenesis as a special issue. Basing on the conference theme, "Enhanced diagnosis, treatment and management of different cancers”, the speakers recommended organizing the conference in the field of Cancer Science and Therapy in the coming years also.

We are obliged to various experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2014. With the unique feedback from the conference,


Past Reports  Gallery  

Cancer Science-2013

 

The 3rd World Congress on Cancer Science & Therapy was organized by OMICS Group Inc., during October 21-23, 2013 at Double Tree by Hilton Hotel San Francisco Airport, USA. Active participation and generous response was received from the Organizing Committee Members, Editorial Board Members of OMICS Group Journals, scientists, researchers, as well as experts in the cancer research, Non-government organizations, and students from diverse groups who made this conference as one of the most successful and productive events in 2013 from OMICS Group.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who have driven this event into the path of success.

The conference was initiated with a warm welcome note from Honorable guests. The proceedings went through interactive sessions and panel discussions headed by Jimmy T. Efird, Brody School of Medicine, USA; honorable Moderator for the conference.

The conference proceedings were carried out through various Keynote-presentations by:

  • Dr. Stewart Sell, Wadsworth Center, USA
  • Dr. Michael Retsky, Harvard School of Public Health, USA
  • Dr. Jimmy T. Efird, Brody School of Medicine, USA
  • Dr. Sudhakar Akul Yakkanti, SRI International, USA
  • Dr. Sherry A. Bradford, Buffalo School of Medical and Biomedical Sciences, USA

Also, the conference proceeding was encouraged through the wonderful workshop session on “ Animal Models of Cancer Therapy” organized by Dr. Dorothee Herlyn, The Wistar Institute, USA

OMICS Group has taken the privilege of felicitating Cancer Science-2013 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2013. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group Journal of Cancer Science & Therapy and Journal of Carcinogenesis & Mutagenesis as a special issue. Basing on the conference theme, "Innovations and Novel Therapeutic Strategies in Cancer Science speakers recommended organizing the conference in the field of Cancer Science and Therapy also in the next year.

We are also obliged to various experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2013. With the unique feedback from the conference.


Past Reports  Gallery  

Radiology-2013

 

OMICS Group organized an International Conference on Radiology and Imaging which was held during August 14-16, 2013 in Holiday Inn Chicago Northshore, USA. The congress was organized with the goal of providing a platform for the future development of the discipline. Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from scientists, researchers and NIH, students who made this conference as one of the most successful events in 2013 from OMICS Group.

The conference was carried out through the following sessions:

  • Acquisition of Radiological Images
  • Interventional Radiology Procedures
  • Applications of Radiography
  • Disorders of Interventional Radiology
  • Radiation Therapy
  • Radiology for the Non-Radiologist
  • Advances in Imaging
  • Diagnostic Imaging Techniques
  • Radiopharmaceuticals
  • PET/MRI versus PET/CT Hybrid

 

The main theme of this Conference was "An Insight into Advanced Methodologies in Radiology".

The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the Keynote forum.

Keynote speakers:

  • Ravinder Reddy, University of Pennsylvania, USA
  • Hollis Potter, Hospital for Special Surgery, USA
  • Xiaohong Zhou, University of Illinois, USA

Some of the eminent speeches were given by:

  • Jiang Du, University of California, USA
  • Michael L. Goris, Stanford University School of Medicine, USA
  • Hua Guo, Tsinghua University School of Medicine, China
  • Morio Sato, Wakayama Medical University, Japan
  • Shuo li, GE Healthcare, Canada

Dr. David Cheng, Yale University, USA, acted as a moderator and helped in making this conference a huge success.

All accepted abstracts have been indexed in OMICS Journal of Radiology as a special issue.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 17-19, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
cancersummit@conferenceseries.net
Sponsors / Exhibiting / Advertising.
cancersummit@insightconferences.com
General Queries.
cancersummit@insightconferences.com

View Proceedings of Previous Conferences

Cancer Therapy Proceedings
World Cancer therapy Proceedings
Euro Cancer Proceedings
Indo Cancer Proceedings
Authorization Policy

By registering for the conference you grant permission to Conferenceseries Ltd to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.